China Lipid Market Size & Outlook, 2022-2030
China lipid market, 2018-2030 (US$M)
Related Markets
China lipid market highlights
- The China lipid market generated a revenue of USD 550.5 million in 2022 and is expected to reach USD 989.8 million by 2030.
- The China market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 550.5 million |
| Market revenue in 2030 | USD 989.8 million |
| Growth rate | 7.6% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, China accounted for 5.9% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China lipid market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 989.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.46% in 2022. Horizon Databook has segmented the China lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The rising risks of sudden health crises have compelled the Chinese to become highly cautious about their diet and health. Children up to 10 years of age are the major consumers of dietary supplements in China. According to the National Center of Biotechnology Information, around 20.4% of primary school students in China consume dietary supplements regularly.
This is a major driving factor for the growth of the lipid market in the country. Lipids are among the essential ingredients for the formulation of functional beverages. The rising consumption of beverages can be attributed to the rising population coupled with growing individual income.
Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health. This factor is expected to augment the demand for lipids in the manufacturing of beverages in China over the projected years.
Reasons to subscribe to China lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China lipid market , including forecasts for subscribers. This country databook contains high-level insights into China lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China lipid market size, by phase, 2018-2030 (US$M)
China Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
